Low dose recombinant human growth hormone normalizes bone metabolism and cortical bone density and improves trabecular bone density in growth hormone deficient adults without causing adverse effects

Clinical Endocrinology

Volumn 45, Issue 1, 1996, Pages 27-32

  Amato, Giovanni ^a,b   Izzo, Giovanni ^a   La Montagna, Giovanni ^a   Bellastella, Antonio ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b NONE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

OSTEOCALCIN; PARATHYROID HORMONE; PROCOLLAGEN TYPE 3 AMINOPROPEPTIDE; RECOMBINANT GROWTH HORMONE; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C; VITAMIN D;

ADULT; ARTICLE; BONE DENSITY; BONE METABOLISM; BONE MINERAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GROWTH HORMONE DEFICIENCY; HUMAN; MALE; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ADULT; BIOLOGICAL MARKERS; BONE AND BONES; BONE DENSITY; DRUG ADMINISTRATION SCHEDULE; FEMALE; GROWTH DISORDERS; GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; MALE; OSTEOCALCIN; PARATHYROID HORMONE; PEPTIDE FRAGMENTS; PROCOLLAGEN; RECOMBINANT PROTEINS; VITAMIN D;

EID: 0030011159     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2265.1996.tb02056.x     Document Type: Article

References (61)

1. Amato, G., Carella, C., Fazio, S., La Montagna, G., Cittadini, A., Sabatini, D., Marciano-Mone, C., Saccà, L. & Bellastella, A. (1993) Body composition, bone metabolism, and heart structure and function in growth hormone (GH) deficient adults before and after GH replacement therapy at low dose. Journal of Clinical Endocrinology and Metabolism, 77, 1671-1676.
2. Aurbach, G.D., Marx, S.J. & Spiegel, A.M. (1992) Metabolic bone disease. In Williams: Textbook of Endocrinology (eds J.D. Wilson & D.W. Foster), pp. 1477-1487, Saunders Company.
3. Balducci, R., Toscano, V., Pasquino, A.M., Mangiantini, A., Municchi, G., Armenise, P., Terracina, S., Prossomariti, G. & Boscherini, B. (1995) Bone turnover and bone mineral density in young adult patients with panhypopituitarism before and after long-term growth hormone therapy. European Journal of Endocrinology, 132, 42-46.
4. Barnard, R., Ng, K.W., Martin, T.J. & Waters, M.J. (1991) Growth hormone (GH) receptors in clonal osteoblastic-like cells mediate a mitogenic response to GH. Endocrinology, 128, 1459-1464.
5. Bengtsson, B-A., Staffan, E., Lonn, L., Kvist, H., Stokland, A., Lindstedt, G., Bosaeus, I., Tolli, J., Sjostrom, L. & Isaksson, O.G.P. (1993) Treatment of adults with growth hormone (GH) deficiency with recombinant GH. Journal of Clinical Endocrinology and Metabolism. 76, 309-317.
6. Beshyah, S.A., Freemantle, C., Shahi, M., Anyaoku, V., Merson, S., Lynch, S., Skinner, E., Sharp, P., Foale, R. & Johnston, D.G. (1995a) Replacement treatment with biosynthetic human growth hormone in growth hormone-deficient hypopituitary adults. Clinical Endocrinology, 42, 73-84.
7. Beshyah, S.A., Kyd, P., Thomas, E., Fairney, A. & Johnston, D.G. (1995b) The effects of prolonged growth hormone replacement on bone metabolism and bone mineral density in hypopituitary adults. Clinical Endocrinology, 42, 249-254.
8. Beshyah, S.A., Thomas, E., Kyd, P., Sharp, P., Fairney, A. & Johnston, D.G. (1994) The effect of growth hormone replacement therapy in hypopituitary adults on calcium and bone metabolism. Clinical Endocrinology, 40, 383-391.
9. Birnbaum, R.S. & Wiren, K.M. (1994) Changes in insulin-like growth factor-binding protein expression and secretion during the proliferation, differentiation, and mineralization of primary cultures of rat osteoblasts. Endocrinology, 135, 223-230.
10. Blum, W.F., Albertsson-Wikland, K., Rosberg, S. & Ranke, B.R. (1993) Serum levels of insulin-like growth factor I (IGF-I) and IGF binding protein 3 reflect spontaneous growth hormone secretion. Journal of Clinical Endocrinology and Metabolism, 76, 1610-1616.
11. Bonjour, J.P., Theintz, G., Buches, B., Slosman, D. & Rizzoli, R. (1991) Critical years and stages of puberty for spinal and femoral bone mass accumulation during adolescence. Journal of Clinical Endocrinology and Metabolism, 73, 555-563.
12. Bouillon, R. (1991) Growth hormone and bone. Hormone Research, 36 (Suppl. 1), 49-55.
13. Burstein, S., Chen, I-W. & Tsang, R.C. (1983) Effects of growth hormone replacement therapy on 1,25-dihydroxyvitamin D and calcium metabolism. Journal of Clinical Endocrinology and Metabolism, 56, 1246-1251.
14. Canalis, E. (1983) The hormonal and local regulation of bone formation. Endocrine Reviews, 42, 62-77.
15. Chipman, J.J., Zerwekh, J., Nicar, M., Marks, J. & Pak, C.Y.C. (1980) Effect of growth hormone administration: reciprocal changes in serum 1-25-dihydroxyvitamin D and intestinal calcium absorption. Journal of Clinical Endocrinology and Metabolism, 51, 321-324.
16. Cohen, P., Fielder, P.J., Hasegawa, Y., Frisch, H., Giudice, L.C. & Rosenfeld, R.G. (1991) Clinical aspects of insulin-like growth factor binding proteins. Acta Endocrinologica, 124, 74-85.
17. Corpas, E., Harman, S.M. & Blackman, M.R. (1993) Human growth hormone and human aging. Endocrine Reviews, 14, 20-39.
18. Cuneo, R.C., Salomon, F., McGauley, G.A. & Sönksen, P.H. (1992) The growth hormone deficiency syndrome in aduls. Clinical Endocrinology, 37, 387-397.
19. De Boer, H., Block, G.J., van Lingen, A., Teule, G.J.J., Lips, P. & van der Veen, E.A. (1994) Consequences of childhood-onset growth hormone deficiency for adult bone mass. Journal of Bone and Mineral Research, 9, 1319-1326.
20. De Boer, H., Blok, G-J. & van der Veen, E. A. (1995) Clinical aspects of growth hormone deficiency in adults. Endocrine Reviews, 16, 63-86.
21. Degerblad, M., Elgindy, N., Hall, K., Sjoberg, H.E. & Thorén, M. (1992) Potent effect of recombinant growth hormone on bone mineral density and body composition in adults with panhypopituitarism. Acta Endocrinologica, 126, 387-393.
22. Ezzat, S., Melmed, S., Endres, D., Eyre, D.R. & Singer, F.R. (1993) Biochemical assessment of bone formation and resorption in acromegaly. Journal of Clinical Endocrinology and Metabolism, 76, 1452-1457.
23. Hasegawa, Y., Hasegawa, T., Aso, T., Kotoli, S., Nose, O., Ohyama, Y., Araki, K., Tanaka, T., Saisyo, S., Yokoya, S., Nishi, Y., Miyamoto, S., Sasaki, N., Kurimoto, F., Stene, M. & Tsuchiya, Y. (1994) Clinical utility of insulin-like growth factor binding protein-3 in the evaluation and treatment of short children with suspected growth hormone deficiency. European Journal of Endocrinology, 131, 27-32.
24. Ho, K.K.Y. & Hoffman, D.M. (1993) Aging and growth hormone. Hormone Research, 40, 80-86.
25. Hock, J.M., Centrella, M. & Canalis, E. (1988) Insulin-like growth factor I has independent effects on bone matrix formation and cell replication. Endocrinology, 122, 254-260.
26. Holloway, L., Butterfield, G., Hintz, R.L., Gesundheit, N. & Marcus, R. (1994) Effects of recombinant human growth hormone on metabolic indices, body composition, and bone turnover in healthy elderly women. Journal of Clinical Endocrinology and Metabolism, 79, 470-479.
27. Holmes, S.J., Economou, G. Whitehouse, R.W., Adams, J.E. & Shalet, S.M. (1994) Reduced bone mineral density in patients with adult onset growth hormone deficiency. Journal of Clinical Endocrinology and Metabolism, 78, 669-674.
28. Holmes, S.J., Whitehouse, R.W., Swindell, R., Economou, G., Adams, J.E. & Shalet, S.M (1995) Effect of growth hormone replacement on bone mass in adults with adult onset growth hormone deficiency. Clinical Endocrinology, 42, 627-633.
29. Hyer, L.S., Rodin, D.A., Tobias, J.H., Leiper, A. & Nussey, S.S. (1992) Growth hormone deficiency during puberty reduces adult bone mineral density. Archives of Diseases of Children, 67, 1472-1474.
30. Inzucchi, S.E. & Robbins, R.J. (1994) Clinical review 61: effects of growth hormone on human bone biology. Journal of Clinical Endocrinology and Metabolism, 79, 691-694.
31. Johansson, A.J., Lindh, E. & Ljunghall, S. (1993) IGFs: function and clinical importance 4 growth hormone, insuline-like growth factor I, and bone: clinical review. Journal of Internal Medicine, 234, 553-560.
32. Jørgensen, J.O.L. (1991) Human growth hormone replacement therapy: Pharmalogical and clinical aspects. Endocrine Reviews, 12, 189-207.
33. Jorgensen, J.O.L., Pedersen, S.A., Thuesen, L., Jørgensen, J., Ingemann-Hanse, T. & Christiansen, J.S. (1989) Beneficial effects of growth hormone treatment in GH deficient adults. Lancet, i, 1221-1225.
34. Kaplan, S.L. (1993) The newer uses of growth hormone in adults. Advances in Internal Medicine, 38, 287-301.
35. Kaufman, J-M., Taelman, P., Vermeulen, A. & Vandeveghe, M. (1991) Bone mineral status in growth hormone-deficient males with isolated and multiple pituitary deficiencies of childhood onset. Journal of Clinical Endocrinology and Metabolism, 74, 118-123.
36. Leung, D.W., Spencer, S.A., Cachines, G., Hammonds, R.G., Collins, C., Henzel, W.J., Barnard, R., Waters, M.J. & Wood, W.J. (1987) Growth hormone receptor and serum binding protein: purification, cloning, and expression. Nature, 330, 537-543.
37. Mochizuki, H., Hakeda, Y., Wakatsuki, N., Usui, N., Akashi, S., Sato, T., Tanaka, K. & Kumegawa, M. (1992) Insulin like growth factor-1 supports formation and activation of osteoclasts. Endocrinology, 131, 1075-1080.
38. Møller, J., Jøorgensen, J.O.L., Lauersen, T., Frystyk, J., Nacraa, R.W., Ørskov, H. & Christiansen, J.S. (1993) Growth hormone dose regimens in adult GH deficiency: effects on biochemical growth markers and metabolic parameters. Clinical Endocrinology, 39, 403-408.
39. O'Halloran, D., Tsatsoulis, A., Whitehouse, R.W., Holmes, S.J., Adams, J.K. & Shalet, S.M. (1993) Increased bone density after recombinant human growth hormone therapy in adults with isolated GH deficiency. Journal of Clinical Endocrinology and Metabolism, 76, 1344-1348.
40. Ott, S.M. (1991) Bone density in adolescents. New England Journal of Medicine, 325, 1646-1647.
41. Ott, S.M. (1994) Bone mass measurements: reasons to be cautious. British Medical Journal, 308, 931-932.
42. Raisz, L.G. (1988) Local and systemic factors in the pathogenesis of osteoporosis. New England Journal of Medicine, 318, 818-828.
43. Riggs, B.L., Wahner, H.W., Dunn, W.L., Mazess, R.B., Offord, K.P. & Melton III, L.J. (1981) Differential changes in bone mineral density of the appendicular and axial skeleton with aging. Journal of Clinical Investigation, 67, 328-335.
44. Rosen, T., Hansson, T., Granhed, H., Szucs, J. & Bengtsson, B-A. (1993) Reduced bone mineral content in adult patients with growth hormone deficiency. Acta Endocrinologica, 129, 201-206.
45. Ross, R.J.M. (1993) Growth hormone replacement in adults: what dose? Clinical Endocrinology, 39, 401-402.
46. Rubin, C.D. (1993) Southwestern internal medicine conference: growth hormone-aging and osteoporosis. American Journal of The Medical Sciences, 35, 120-129.
47. Rudman, D., Kutner, M.H., Rogers, M.C., Lubin, M.F., Fleming, G.A. & Bain, R.P. (1981) Impaired growth hormone secretion in adult population. Relation to age and adiposity. Journal of Clinical Investigation, 67, 1361-1369.
48. Salomon, F., Cuneo, R.C., Hesp, R. & Sonksen, P.H. (1989) The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. New England Journal of Medicine, 321, 1797-1803.
49. Sambrook, P., Kelly, P. & Eisman, J. (1993) Bone mass and ageing. Baillière's Rheumatology, 1, 445-457.
50. Sartorio, A., Conti, A., Monzani, M., Morabito, F. & Faglia, G. (1993) Growth hormone treatment in adults with GH deficiency: Effects on new biochemical markers of bone and collagen turnover. Journal of Endocrinological Investigation, 16, 893-898.
51. Schmid, C., Schlapfer, I., Peter, M., Boni-Scheteler, M., Schwander, J., Zapf, J. & Froesch, E.R. (1994) Growth hormone and parathyroid hormone stimulate IGFBP-3 in rat osteoblasts. American Journal of Physiology, 267, E226-233.
52. Slootweg, M.C. (1993) Growth hormone and bone. Hormone and Metabolic Research, 25, 335-343.
53. Slootweg, M.C., Most, W.W., van Beck, E., Schot, L.P.C., Papopoulos, S.E. & Lowik, C.W.G.M. (1992) Osteoclast formation together with interleukin-6 production in mouse long bones is increased by insulin-like growth factor-I. Journal of Endocrinology, 132, 433-438.
54. Stracke, H., Schulz, A., Moeller, D., Rossol, S. & Schatz, H. (1984) Effect of growth hormone on osteoblasts and demonstration of somatomed-C/IGF-I in bone organ culture. Acta Endocrinologica, 107, 16-24.
55. Thoren, M., Soop, M., Degerblad, M & Saaf, M. (1993) Preliminary study of the effects of growth hormone substitution therapy on bone mineral density and serum osteocalcin levels in adults with growth hormone deficiency. Acta Endocrinologica, 128 (Suppl. 2), 41-43.
56. Thorner, M.O. & Vance, M.L. (1988) Growth hormone. Journal of Clinical Investigation, 82, 745-747.
57. Vance, M.L. (1990) Growth hormone for the elderly? New England Journal of Medicine, 323, 52-54.
58. van der Veen, E.A. & Netelenbos, J.C. (1990) Growth hormone (replacement) therapy in adults: bone and calcium metabolism. Hormone Research, 33 (Suppl. 4), 65-68.
59. Vandeweghe, M., Taelman, P. & Kaufman, J-M. (1993) Short and long-term effects of growth hormone treatment on bone turnover and bone mineral content in adult growth hormone-deficient males. Clinical Endocrinology, 39, 409-415.
60. Wuster, C. (1993) Growth hormone and bone metabolism. Acta Endocrinologica, 128 (Suppl. 2), 14-18.
61. Zadik, Z., Chalew, S.A., McCarter, R.J., Meistas, M. & Kowarski, A.A. (1985) The influence of age on the 24-hour integrated concentration of growth hormone in normal individuals. Journal of Clinical Endocrinology and Metabolism, 60, 513-516.